AAAAAA
Results: 1-25/69
Authors:
KREUZ W
ESCURIOLAETTINGSHAUSEN C
FUNK M
SCHMIDT H
KORNHUBER B
Citation: W. Kreuz et al., WHEN SHOULD PROPHYLACTIC TREATMENT IN PATIENTS WITH HEMOPHILIA-A AND HEMOPHILIA-B START - THE GERMAN EXPERIENCE, Haemophilia, 4(4), 1998, pp. 413-417
Authors:
FUNK M
SCHMIDT H
ESCURIOLAETTINGSHAUSEN C
PONS S
DZINAJ T
WEIMER C
KORNHUBER B
KREUZ W
Citation: M. Funk et al., RADIOLOGICAL AND ORTHOPEDIC SCORE IN PEDIATRIC HEMOPHILIC PATIENTS WITH EARLY AND LATE PROPHYLAXIS, Annals of hematology, 77(4), 1998, pp. 171-174
Authors:
VELDMAN A
MARTIN H
FAUTH F
POTZSCH B
SCHARRER I
ETTINGSHAUSEN CE
HOELZER D
KREUZ W
GOETHE JW
Citation: A. Veldman et al., A NEW OPTION IN THE TREATMENT OF VOD AFTER BMT - CONTINUOUS-INFUSION OF RECOMBINANT TISSUE-PLASMINOGEN ACTIVATOR AND PROTEIN-C, Bone marrow transplantation, 21, 1998, pp. 834-834
Authors:
BECKER S
HELLER C
GROPP F
SCHARRER I
KREUZ W
Citation: S. Becker et al., THROMBOPHILIC DISORDERS IN CHILDREN WITH CEREBRAL INFARCTION, Lancet, 352(9142), 1998, pp. 1756-1757
Authors:
KREUZ W
VELDMAN A
ESCURIOLAETTINGSHAUSEN C
SCHNEIDER W
BEEG T
Citation: W. Kreuz et al., PROTEIN-C CONCENTRATE FOR MENINGOCOCCAL PURPURA FULMINANS, Lancet, 351(9107), 1998, pp. 986-987
Authors:
GRINGERI A
KREUZ W
ESCURIOLAETTINGHAUSEN C
SANTAGOSTINO E
SAGUER IM
BADER R
BUDDE U
MANNUCCI PM
Citation: A. Gringeri et al., ANTI-FVIII INHIBITOR INCIDENCE IN PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA EXPOSED TO KOGENATE(R) (GIPSI-GERMAN-ITALIAN PUP STUDY ON INHIBITOR), Thrombosis research, 91(3), 1998, pp. 13-13
Authors:
FIORE S
MAZZOLA G
VIGANODANGELO S
BONDEL M
FRANCOIS D
HUBER A
KONRAD D
HASSELMAN D
KREUZ W
LENZ E
DANGELO A
Citation: S. Fiore et al., HIGH PREVALENCE OF SEVERE, TRANSIENT AUTOIMMUNE PROTEIN-S DEFICIENCY IN YOUNG-PATIENTS WITH PURPURA FULMINANS OR EXTENSIVE VENOUS THROMBOEMBOLISM ASSOCIATED WITH VARICELLA INFECTION, Thrombosis research, 91(3), 1998, pp. 192-192
Authors:
HELLER C
BECKER S
GROPP F
LENZ E
KREUZ W
Citation: C. Heller et al., ASSOCIATION OF FACTOR-V-LEIDEN MUTATION WITH ARTERIAL AND VENOUS THROMBOEMBOLISM IN CHILDHOOD, Thrombosis and haemostasis, 1997, pp. 1283-1283
Authors:
GRINGERI A
KREUZ W
ESCURIOLAETTINGHAUSEN C
SIRACUSANO L
MARTINEZSAGUER I
BADER R
BUDDE U
MANNUCCI PM
Citation: A. Gringeri et al., ANTI-FVIII INHIBITOR INCIDENCE IN PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA EXPOSED TO KOGENATE(R) (GIPSI-GERMAN-ITALIAN PUP STUDY ON INHIBITOR), Thrombosis and haemostasis, 1997, pp. 2642-2642
Authors:
MENTZER D
BURGSMULLER G
HELLER C
ANDRITSCHKE K
SCHARRER I
KREUZ W
Citation: D. Mentzer et al., SUFFICIENT INCREASE OF CLOTTING FACTORS AFTER REDUCED DDAVP TEST-DOSAGE IN VON-WILLEBRANDS-DISEASE TYPE-I, Thrombosis and haemostasis, 1997, pp. 2839-2839
Authors:
FUNK M
MENTZER D
KLARMANN D
CINATL J
KREUZ W
KORNHUBER B
Citation: M. Funk et al., VIRAL LOAD AND SYNCYTIUM INDUCING HIV-1 VARIANTS INDICATE PROGRESSIONOF PERINATAL HIV-INFECTION, European journal of pediatrics, 156(4), 1997, pp. 339-339
Authors:
VELDMAN A
ESCURIOLAETTINGSHAUSEN C
BEEG T
SCHNEIDER W
KREUZ W
Citation: A. Veldman et al., TREATMENT OF DIC IN SEPTIC SHOCK WITH PROTEIN-C CONCENTRATE, Blood, 90(10), 1997, pp. 3271-3271
Authors:
AUERSWALD G
AUBERGER K
KREUZ W
Citation: G. Auerswald et al., CONTINUOUS-INFUSION, A MODERN, ALTERNATIVE FORM OF THERAPY ESPECIALLYFOR V.-WILLEBRAND-DISEASE TYPE-III, Blood, 90(10), 1997, pp. 164-164
Authors:
BECKER S
HELLER C
LENZ E
GROPP F
KREUZ W
Citation: S. Becker et al., SIGNIFICANCE OF THROMBOPHILIC DISORDERS FOR IDIOPATHIC CEREBRAL ARTERIAL INFARCTION COMPARED TO VENOUS THROMBOSIS IN CHILDREN, Blood, 90(10), 1997, pp. 659-659
Authors:
ETTINGSHAUSEN CE
GRINGERI A
BUDDE U
MANNUCCI PM
KREUZ W
LUSHER J
Citation: Ce. Ettingshausen et al., INHIBITOR DEVELOPMENT IN PREVIOUSLY UNTREATED PATIENTS (PUP) WITH HEMOPHILIA-A TREATED WITH KOGENATE(R) - (GIPSI - GERMAN ITALIAN PUP STUDYON INHIBITOR DEVELOPMENT), Blood, 90(10), 1997, pp. 687-687
Authors:
KLINGE J
AUERSWALD G
BUDDE U
KLOSE H
KREUZ W
LENK H
SCANDELLA D
Citation: J. Klinge et al., THE IMMUNE-RESPONSE TO FACTOR-VIII IN HEMOPHILIA-A PATIENTS IS MORE COMPLEX THAN SUGGESTED BY THE BETHESDA ASSAY, Blood, 90(10), 1997, pp. 2056-2056
Authors:
DZINAJ T
FUNK M
SCHMIDT H
BOTTGER S
GUNGOR T
KLARMANN D
KREUZ W
Citation: T. Dzinaj et al., RADIOLOGICAL SCORE IN PEDIATRIC HEMOPHILIC PATIENTS WITH EARLY AND LATE-ONSET OF FACTOR-VIII - PROPHYLAXIS, Thrombosis and haemostasis, 76(4), 1996, pp. 630-631
Authors:
NOWAKGOTTL U
AUBERGER K
GOBEL U
KREUZ W
SCHNEPPENHEIM R
VIELHABER H
ZENZ W
ZIEGER B
Citation: U. Nowakgottl et al., INHERITED DEFECTS OF THE PROTEIN-C ANTICOAGULANT SYSTEM IN CHILDHOOD THROMBOEMBOLISM, European journal of pediatrics, 155(11), 1996, pp. 921-927
Authors:
FUNK M
JOSEPHSTEINER J
HERNAIZDRIEVER P
MENTZER D
GOHLICHRATMANN G
BOLLINGER M
KREUZ W
KORNHUBER B
JACOBI G
Citation: M. Funk et al., CNS AFFECTION IN PERINATALLY HIV-INFECTED CHILDREN, Klinische Padiatrie, 208(5), 1996, pp. 299-303
Authors:
KREUZ W
ESCURIOLAETTINGSHAUSEN C
MARTINEZSAGUER I
GUNGOR T
KORNHUBER B
Citation: W. Kreuz et al., EPIDEMIOLOGY OF INHIBITORS IN HEMOPHILIA-A, Vox sanguinis, 70, 1996, pp. 2-8
Authors:
KLARMANN D
KREUZ W
JOSEPHSTEINER J
EHRENFORTH S
Citation: D. Klarmann et al., HEPATITIS-C AND PASTEURIZED C1-INHIBITOR CONCENTRATE, Transfusion, 36(1), 1996, pp. 84-85
Authors:
KLOSE HJ
AUERSWALD G
ESCURIOLAETTINGSHAUSEN C
KREUZ W
LENK H
MARTINEZSAGUER I
BUDDE U
Citation: Hj. Klose et al., INCIDENCE OF INHIBITORS IN PREVIOUSLY UNTREATED HEMOPHILIA PATIENTS -PRELIMINARY-RESULTS OF A PROSPECTIVE MULTICENTER STUDY OF THE PEDIATRIC WORKING GROUP TO THE GTH MAN-SOCIETY-OF-THROMBOSIS-AND-HEMOSTASIS-RESEARCH), Blood, 88(10), 1996, pp. 3031-3031
Authors:
KREUZ W
EHRENFORTH S
FUNK M
AUERSWALD G
MENTZER D
JOSEPHSTEINER J
BEEG T
KLARMANN D
SCHARRER I
KORNHUBER B
Citation: W. Kreuz et al., IMMUNE TOLERANCE THERAPY IN PEDIATRIC HEMOPHILIACS WITH FACTOR-VIII INHIBITORS - 14 YEARS FOLLOW-UP, Haemophilia, 1(1), 1995, pp. 24-32
Authors:
WEBER B
RABENAU H
BERGER A
SCHEUERMANN EH
STASZEWSKI S
KREUZ W
SCHARRER I
SCHOEPPE W
DOERR HW
Citation: B. Weber et al., SEROPREVALENCE OF HCV, HAV, HBV, HDV, HCMV AND HIV IN HIGH-RISK GROUPS FRANKFURT AM, GERMANY, Zentralblatt fur Bakteriologie, 282(1), 1995, pp. 102-112
Authors:
CHANDRA P
DEMIRHAN I
HOFMANN D
CHANDRA A
KORNHUBER B
KREUZ W
SCHOFER H
MILBRADT R
Citation: P. Chandra et al., TRANSACTIVATOR PROTEIN AS A TARGET FOR DEVELOPING INHIBITORS OF HIV-1REPLICATION AND ITS ROLE AS A PATHOPHYSIOLOGICAL MARKER, AIDS research and human retroviruses, 11, 1995, pp. 161-161